RNA Supply Chain Solutions
-
Enabling mRNA Manufacturing For RNA-Based Vaccines And Therapeutics
2/9/2026
Learn about next-generation RNA polymerases that support diverse cap analog chemistries and modified nucleotides, ensuring high capping efficiency and sequence integrity for complex therapeutics.
-
in vivo-jetRNA®+
9/14/2022
Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry. -
High-Fidelity Nuclease For Therapeutic Breakthroughs
10/28/2024
The hfCas12Max nuclease offers superior gene editing with high fidelity, broad PAM recognition, minimal off-target effects, and compatibility across cell types for therapeutic applications.
-
Synthetic Research Grade sgRNA Manufacturing For CRISPR Experiments
11/28/2023
Consistently achieve high editing efficiency and quick turnaround time in as little as 7 days with synthetic sgRNA that pave your way to a successful CRISPR experiment.
-
T Cell Kit For mRNA On NanoAssemblr Spark
4/14/2022
The GenVoy-ILM T Cell Kit for mRNA is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr Spark instrument and cartridges.